(Q34741897)

4 August 2017

1 reference

title

The sympathetic nervous system and obesity: role in aetiology and treatment (English)

1 reference

4 August 2017

0 references

0 references

Snitker S

1

1 reference

4 August 2017

Macdonald I

series ordinal

2

1 reference

4 August 2017

Ravussin E

series ordinal

3

1 reference

4 August 2017

Astrup A

series ordinal

4

1 reference

4 August 2017

language of work or name

1 reference

1 May 2000

1 reference

4 August 2017

1 reference

4 August 2017

1

1 reference

4 August 2017

1

1 reference

4 August 2017

5-15

1 reference

Metabolic actions of catecholamines in man.

4 August 2017

1 reference

https://api.crossref.org/works/10.1046%2FJ.1467-789X.2000.00001.X

Regional sympathetic nervous activation after a large meal in humans.

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1467-789X.2000.00001.X

Plasma catecholamines--analytical challenges and physiological limitations

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1467-789X.2000.00001.X

Feeding, fasting and starvation: factors affecting fuel utilization

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1467-789X.2000.00001.X

The sympathetic response to euglycaemic hyperinsulinaemia. Evidence from microelectrode nerve recordings in healthy subjects.

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1467-789X.2000.00001.X

Catabolic effects of thyroid hormone excess: the contribution of adrenergic activity to hypermetabolism and protein breakdown.

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1467-789X.2000.00001.X

Human beta-2 adrenoceptor gene polymorphisms are highly frequent in obesity and associate with altered adipocyte beta-2 adrenoceptor function

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1467-789X.2000.00001.X

Synergistic effect of polymorphisms in uncoupling protein 1 and beta3-adrenergic receptor genes on basal metabolic rate in obese Finns.

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1467-789X.2000.00001.X

Determinants of 24-hour energy expenditure in man. Methods and results using a respiratory chamber

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1467-789X.2000.00001.X

Energy expenditure and intake in infants born to lean and overweight mothers

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1467-789X.2000.00001.X

Metabolic rate and physical development in children at risk of obesity

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1467-789X.2000.00001.X

Reduced rate of energy expenditure as a risk factor for body-weight gain

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1467-789X.2000.00001.X

The thermic effect of food and obesity: a critical review

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1467-789X.2000.00001.X

Two-week stimulation or blockade of the sympathetic nervous system in man: influence on body weight, body composition, and twenty four-hour energy expenditure

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1467-789X.2000.00001.X

Reduced sympathetic nervous activity. A potential mechanism predisposing to body weight gain

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1467-789X.2000.00001.X

Hyperinsulinemia produces both sympathetic neural activation and vasodilation in normal humans

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1467-789X.2000.00001.X

The biochemical effect of the naturally occurring Trp64-->Arg mutation on human beta3-adrenoceptor activity

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1467-789X.2000.00001.X

Pharmacological characterization of a recently described human beta 3- adrenergic receptor mutant

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1467-789X.2000.00001.X

Effects of mutations in the human uncoupling protein 3 gene on the respiratory quotient and fat oxidation in severe obesity and type 2 diabetes

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1467-789X.2000.00001.X

A low sympathoadrenal activity is associated with body weight gain and development of central adiposity in Pima Indian men.

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1467-789X.2000.00001.X

Effects of nutrient intake on sympathoadrenal activity and thermogenic mechanisms

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1467-789X.2000.00001.X

What do pharmacological approaches to obesity management offer? Linking pharmacological mechanisms of obesity management agents to clinical practice.

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1467-789X.2000.00001.X

The role of low-fat diets and fat substitutes in body weight management: what have we learned from clinical studies?

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1467-789X.2000.00001.X

Beta-agonists as antiobesity, antidiabetic and nutrient partitioning agents

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1467-789X.2000.00001.X

Sibutramine in weight control: a dose-ranging, efficacy study

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1467-789X.2000.00001.X

Body weight reduction, sympathetic nerve traffic, and arterial baroreflex in obese normotensive humans.

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1467-789X.2000.00001.X

Linkage Between Markers in the Vicinity of the Uncoupling Protein 2 Gene and Resting Metabolic Rate in Humans

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1467-789X.2000.00001.X

Replacement of dietary fat by sucrose or starch: Effects on 14 d ad libitum energy intake, energy expenditure and body weight in formerly obese and never-obese subjects

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1467-789X.2000.00001.X

The effect of sibutramine on energy expenditure and appetite during chronic treatment without dietary restriction

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1467-789X.2000.00001.X

10.1046/J.1467-789X.2000.00001.X

21 January 2018

Identifiers

DOI

1 reference

4 August 2017

1 reference